Therefore, the infiltration of CD146+ invasive cancers into tumor-dissemination tracks is likely dependent on the interaction between CD146 and Laminin 421, and blocking their binding may affect the efficacy of cell–cell interactions and interfere metastasis. This evidence concerns the gene LAMB2 and cancer.